Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating side effects of palliative radiotherapy in cancer patients

Official title: Evaluation of Toxicities in Patients Treated With Palliative Radiotherapy at Policlinico Sant Orsola of Bologna - patieNts treAted wIth palliatiVe radiothErapy - NAIVE

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06760806 · Data updated 2026-11-12

This study tests how well palliative radiotherapy can help cancer patients with symptoms like pain and bleeding feel better.

More Palliative Care trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment7000 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Drugs / interventionsradiation
Locations1 site (Bologna)
StatusRecruiting
StartedJanuary 21, 2021
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJanuary 7, 2025
Trial IDNCT06760806 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult patients with a new or previous diagnosis of malignant neoplasm who are receiving palliative radiotherapy.

Probably not a fit

Patients who choose not to undergo radiotherapy or are enrolled in other studies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the outcomes of palliative radiotherapy in patients with malignant neoplasms, focusing on symptom resolution or alleviation. It examines various treatment settings, dosages, and techniques used for both newly diagnosed and previously treated tumors at the Radiotherapy Unit of Sant Orsola Hospital. The study will analyze the effectiveness of radiotherapy in alleviating symptoms such as pain, bleeding, and obstruction, particularly in patients with bone metastases. By understanding these outcomes, the study seeks to improve palliative care strategies for cancer patients.

Why it matters

Potential benefit: If successful, this study could enhance the quality of life for cancer patients by optimizing palliative radiotherapy treatments.

How similar studies have gone: Other studies have shown that palliative radiotherapy can effectively alleviate cancer-related symptoms, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adult patients of either sex with a new or previous diagnosis of malignant neoplasm since 1st January 2000
* patients treated with paliative radiotherapy
* obtaining of informed consent

Exclusion Criteria:

* adult patients of either sex with a new or previous diagnosis of malignant neoplasm who choose not to undergo radiotherapy treatment
* patients enrolled in other studies
* pregnant or breastfeeding women

Where it's running

  • IRCCS Azienda Ospedaliero - Universitaria di Bologna
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Alessio Giuseppe Morganti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Alessio Giuseppe Morganti, MD
  • Email: alessio.morganti2@unibo.it
  • Phone: 0512143564

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.